GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Minapharm Pharmaceuticals (CAI:MIPH) » Definitions » Retained Earnings

Minapharm Pharmaceuticals (CAI:MIPH) Retained Earnings : E£1,789 Mil (As of Sep. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Minapharm Pharmaceuticals Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Minapharm Pharmaceuticals's retained earnings for the quarter that ended in Sep. 2024 was E£1,789 Mil.

Minapharm Pharmaceuticals's quarterly retained earnings declined from Dec. 2023 (E£1,843 Mil) to Jun. 2024 (E£1,690 Mil) but then increased from Jun. 2024 (E£1,690 Mil) to Sep. 2024 (E£1,789 Mil).

Minapharm Pharmaceuticals's annual retained earnings increased from . 20 (E£0 Mil) to Dec. 2022 (E£1,719 Mil) and increased from Dec. 2022 (E£1,719 Mil) to Dec. 2023 (E£1,843 Mil).


Minapharm Pharmaceuticals Retained Earnings Historical Data

The historical data trend for Minapharm Pharmaceuticals's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Minapharm Pharmaceuticals Retained Earnings Chart

Minapharm Pharmaceuticals Annual Data
Trend Dec22 Dec23
Retained Earnings
1,718.80 1,843.30

Minapharm Pharmaceuticals Quarterly Data
Dec22 Jun23 Sep23 Dec23 Jun24 Sep24
Retained Earnings Get a 7-Day Free Trial - - 1,843.30 1,690.01 1,788.59

Minapharm Pharmaceuticals Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.


Minapharm Pharmaceuticals  (CAI:MIPH) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


Minapharm Pharmaceuticals Business Description

Traded in Other Exchanges
N/A
Address
El-Bardissi Street, 2T Takseem Asmaa Fahmy Street, Heliopolis, Cairo, EGY
Minapharm Pharmaceuticals is a company whose purpose is to produce medicines and chemicals. medical supplies. cosmetics, veterinary medicines, dental supplies, and the production of dietary supplements and herbal medicines. It produces drugs for many segments such as biogenetics, orthopedic, ophthalmology, miscellaneous, dermatology, gastroenterology, cardiology, and uro-gynaecology lines.

Minapharm Pharmaceuticals Headlines

No Headlines